Bach Original Flower Remedies Chestnut Bud
Aesculus Hippocastanum
Nelson Bach Usa Limited
Human Otc Drug
NDC 57687-206Bach Original Flower Remedies Chestnut Bud also known as Aesculus Hippocastanum is a human otc drug labeled by 'Nelson Bach Usa Limited'. National Drug Code (NDC) number for Bach Original Flower Remedies Chestnut Bud is 57687-206. This drug is available in dosage form of Solution. The names of the active, medicinal ingredients in Bach Original Flower Remedies Chestnut Bud drug includes Aesculus Hippocastanum Whole - 5 [hp_X]/.095mL . The currest status of Bach Original Flower Remedies Chestnut Bud drug is Active.
Drug Information:
| Drug NDC: | 57687-206 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Bach Original Flower Remedies Chestnut Bud |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Aesculus Hippocastanum |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Nelson Bach Usa Limited |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Solution |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | AESCULUS HIPPOCASTANUM WHOLE - 5 [hp_X]/.095mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | ORAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 20 Sep, 2022 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 16 Jan, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Nelson Bach USA Limited
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0741273401469
|
| UPC stands for Universal Product Code. |
| UNII: | 2331W47PSX
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 57687-206-10 | 1 BOTTLE, DROPPER in 1 CARTON (57687-206-10) / 10 mL in 1 BOTTLE, DROPPER | 20 Sep, 2022 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose learn from mistakes
Product Elements:
Bach original flower remedies chestnut bud aesculus hippocastanum water aesculus hippocastanum whole aesculus hippocastanum whole glycerin
Indications and Usage:
Use for relief of naturally occurring simple nervous tension
Warnings:
Warnings consult a doctor if symptoms last for more than 7 days or worsen. keep out of reach of children if pregnant or breast-feeding, ask a health professional before use.
Dosage and Administration:
Directions take 2 drops directly on the tongue or add to a beverage & sip. repeat as needed throughout the day. children under 2: ask a doctor before use.
Package Label Principal Display Panel:
Bach original flower remedies chestnut bud
Further Questions:
Questions 800-319-9151 8am-5pm (est) mon-fri